Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Hairy Cell × Bortezomib × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 89 Neoplasms, Plasma Cell 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Leukemia, Myeloid, Acute 6 Immunoglobulin Light-chain Amyloidosis 6 Recurrence 5 Hematologic Neoplasms 4 Waldenstrom Macroglobulinemia 3 Paraproteinemias 3 Neoplasms 3 Lymphoma, Mantle-Cell 3 Lymphoma 3 Renal Insufficiency 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoproliferative Disorders 2 Leukemia 2 Burkitt Lymphoma 2 Breast Neoplasms 2 Amyloidosis 2 beta-Thalassemia 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Thalassemia 1 Sarcoma, Myeloid 1 Plasmacytoma 1 Peripheral Nervous System Diseases 1 Neoplasm, Residual 1

Interventions

Rituximab 8 Vemurafenib 4 Cladribine 4 obinutuzumab 3 Specimen Handling 3 Cyclophosphamide 3 Biopsy 3 ibrutinib 2 binimetinib 2 Lenalidomide 2 Diphenhydramine 2 CT-P10 2 Bendamustine Hydrochloride 2 Acetaminophen 2 venetoclax 1 tovorafenib 1 polatuzumab vedotin 1 pembrolizumab 1 immunotoxin HA22 1 fludarabine phosphate 1 fludarabine 1 encorafenib 1 cc-486 1 brexucabtagene autoleucel 1 acalabrutinib 1 Valganciclovir 1 Therapeutics 1 Spinal Puncture 1 Sodium Chloride 1 Prednisone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡